source
- STAT+: MAHA goes corporateHealth care companies dominate the MAHA Summit, and a look at Trump's watered down effort to lower Medicare drug prices.STAT · 20d ago↗ source
- Lilly's amylin-Zepbound combo shows 23% weight loss in type 2 diabetes patientsEli Lilly reported that its amylin‑Zepbound combination, eloraTZP, produced an average 23.3% weight loss in adults with type 2 diabetes who were also obese or overweight. The result was derived fro…